| Project/Area Number |
18590500
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Medical sociology
|
|---|
| Research Institution | Showa University |
|---|
Principal Investigator |
KAMEI Miwako Showa University, School of Pharmaceutical Sciences, Professor (00237504)
|
|---|
| Project Period (FY) |
2006 – 2007
|
| Project Status |
Completed (Fiscal Year 2007)
|
| Budget Amount *help |
¥2,750,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥150,000)
Fiscal Year 2007: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2006: ¥2,100,000 (Direct Cost: ¥2,100,000)
|
|---|
| Keywords | Qualitative Study / Grounded Theory Ar proach / Non-adherence / Generic drugs / 後発医薬品 / 服薬アドヒアランス / 外来患者 / グラウンデッドセオリーアプローチ |
|---|
| Research Abstract |
Grounded theory based qualitative methodology was utilized to investigate aspects of non-adherence. Recruited 20 patients had a home-based in-depth interview. Interviews were designed to enable a detailed and holistic exploration of medication-related problems from participants' perspectives. Data were recorded and transcribed verbatim to allow qualitative analysis. Two broad categories of medication non-adherence which were examined in the information from within patients' mind such as experiences of side effects, asymptomatic illness- and in the information from outside such as information from their friends, information from the TV etc. These categories of non-adherence were concerns about side effects, cognitive, and lack of information or understanding. In addition, these categories provide a focus for interventions by community pharmacists to support patients in achieving optimal theory outcomes. They demonstrate the need for a comprehensive approach using in-depth interview. We have also conducted the analysis of patients' demand for generic drugs as a factor of non-adherence. The results of conjoint analysis suggested pharmacist' explanation was a primary factor affecting demands for generic drugs.
|
